Vilon 20mg

THIS PRODUCT IS INTEDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly in vitro for testing and laboratory experimentation only. All products information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professional. This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabled as a drug food or cosmetic.

Vilon 20mg                

Vilon 20mg is a synthetic dipeptide bioregulator composed of the amino acid sequence Lys-Glu (KE). It belongs to the family of Khavinson peptide bioregulators, a class of ultra-short regulatory peptides originally developed at the St. Petersburg Institute of Bioregulation and Gerontology for research into thymus biology, immune regulation, cellular aging, and tissue-specific gene expression. Due to its minimal two-amino-acid structure, Vilon has become an important experimental compound for investigating how short peptides influence molecular signaling and immune cell function.

Unlike conventional peptide hormones that primarily activate membrane receptors, Vilon is believed to function through molecular bioregulation. Experimental studies suggest that the Lys-Glu dipeptide may interact with chromatin-associated proteins and DNA regulatory regions, influencing the expression of genes involved in cellular differentiation, immune homeostasis, protein synthesis, and tissue maintenance. These mechanisms remain under active investigation, with much of the available evidence originating from laboratory and preclinical studies.

One of the primary areas of scientific investigation involves thymus function and immune cell biology. Researchers have explored how Vilon influences T-lymphocyte maturation, lymphocyte proliferation, immune signaling pathways, and thymic cellular communication. Laboratory studies suggest that Vilon may contribute to maintaining normal immune cell activity by modulating tissue-specific gene expression and supporting immune homeostasis. Because age-related thymic decline is associated with reduced immune function, Vilon continues to be investigated as a model compound in studies of immune aging and regenerative biology.

Researchers have also investigated Vilon in studies involving cellular senescence, oxidative stress, inflammatory signaling, DNA repair, telomerase biology, and longevity research. Experimental models have examined its potential influence on regulatory genes including SIRT1, FOXO1, TERT, and PARP1, as well as pathways associated with cellular resilience and healthy aging. Although these findings are promising from a mechanistic perspective, they remain primarily preclinical, and additional independent research is required to establish the peptide's full biological profile.

Beyond immunology, Vilon continues to attract scientific interest in molecular genetics, regenerative medicine, peptide engineering, vascular biology, and epigenetics. Scientists continue to investigate how minimal peptide structures regulate complex cellular processes through transcriptional and chromatin-mediated mechanisms. Despite decades of experimental research, Vilon remains strictly a laboratory research compound and has no approved therapeutic indications.

Areas of Scientific Research

Vilon continues to be investigated in laboratory studies involving:

• Thymus biology
• Immune system regulation
• T-lymphocyte maturation
• Gene expression and epigenetic regulation
• Molecular bioregulation
• Cellular aging and longevity research
• Telomerase biology
• SIRT1 and FOXO1 signaling
• DNA repair mechanisms
• Oxidative stress research
• Inflammatory signaling
• Tissue regeneration
• Regenerative medicine
• Peptide engineering

These ongoing investigations continue to improve scientific understanding of how ultra-short peptide bioregulators influence immune function, cellular signaling, and age-related molecular regulation. Current evidence remains primarily preclinical.

Product Quality

Vilon 20mg is supplied as a lyophilized (freeze-dried) powder, a formulation widely used in peptide research because it preserves molecular stability during transportation and long-term laboratory storage. Lyophilization minimizes moisture-related degradation while maintaining peptide integrity until reconstitution according to laboratory protocols.

High-quality research peptides should undergo comprehensive analytical verification using recognized laboratory techniques such as High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm peptide identity, purity, and batch consistency. These quality-control procedures help support reliable, reproducible, and consistent scientific investigations.

This product is intended exclusively for laboratory and scientific research. It is not intended for human consumption, therapeutic use, or veterinary applications.